CN104857517A - 一种恩杂鲁胺软胶囊及其制备方法 - Google Patents
一种恩杂鲁胺软胶囊及其制备方法 Download PDFInfo
- Publication number
- CN104857517A CN104857517A CN201510251067.7A CN201510251067A CN104857517A CN 104857517 A CN104857517 A CN 104857517A CN 201510251067 A CN201510251067 A CN 201510251067A CN 104857517 A CN104857517 A CN 104857517A
- Authority
- CN
- China
- Prior art keywords
- soft capsule
- grace
- mixed
- shandong amine
- gelatin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510251067.7A CN104857517B (zh) | 2015-05-14 | 2015-05-14 | 一种恩杂鲁胺软胶囊及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510251067.7A CN104857517B (zh) | 2015-05-14 | 2015-05-14 | 一种恩杂鲁胺软胶囊及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104857517A true CN104857517A (zh) | 2015-08-26 |
CN104857517B CN104857517B (zh) | 2018-04-27 |
Family
ID=53903975
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510251067.7A Active CN104857517B (zh) | 2015-05-14 | 2015-05-14 | 一种恩杂鲁胺软胶囊及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104857517B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018037310A1 (en) | 2016-08-20 | 2018-03-01 | Ftf Pharma Private Limited | Pharmaceutical composition comprising an androgen receptor inhibitor |
CN109276552A (zh) * | 2017-07-21 | 2019-01-29 | 浙江京新药业股份有限公司 | 一种治疗前列腺癌的抗雄激素类药物软胶囊及其制备方法 |
CN110478347A (zh) * | 2018-05-14 | 2019-11-22 | 成都海创药业有限公司 | 一种hc-1119制剂及其制备方法和用途 |
CN112137989A (zh) * | 2020-10-29 | 2020-12-29 | 瑞阳制药股份有限公司 | 恩杂鲁胺软胶囊速释制剂及其制备方法 |
CN112336700A (zh) * | 2019-08-08 | 2021-02-09 | 河北菲尼斯生物技术有限公司 | 一种稳定的含丁苯酞药物及其制备方法 |
CN113967198A (zh) * | 2020-07-24 | 2022-01-25 | 鲁南制药集团股份有限公司 | 一种甾体cyp17抑制剂胶囊及其制备方法 |
CN114053243A (zh) * | 2020-08-05 | 2022-02-18 | 齐鲁制药有限公司 | 一种恩扎卢胺软胶囊及其制备方法 |
RU2777008C2 (ru) * | 2018-05-14 | 2022-08-02 | Хинова Фармасьютикалс Инк. | Состав hc-1119, способ его получения и применение |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112022833B (zh) * | 2020-11-05 | 2021-02-12 | 上海翰森生物医药科技有限公司 | 一种恩杂鲁胺药物组合物及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014043208A1 (en) * | 2012-09-11 | 2014-03-20 | Medivation Prostate Therapeutics, Inc. | Formulations of enzalutamide |
CN103997894A (zh) * | 2011-07-29 | 2014-08-20 | 麦迪韦逊前列腺治疗股份有限公司 | 乳癌的治疗 |
WO2015022349A1 (en) * | 2013-08-14 | 2015-02-19 | Ratiopharm Gmbh | Dosage form comprising enzalutamide |
WO2015049650A1 (en) * | 2013-10-01 | 2015-04-09 | Glaxosmithkline Intellectual Property (No.2) Limited | Enzalutamide in combination with afuresertib for the treatment of cancer |
-
2015
- 2015-05-14 CN CN201510251067.7A patent/CN104857517B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103997894A (zh) * | 2011-07-29 | 2014-08-20 | 麦迪韦逊前列腺治疗股份有限公司 | 乳癌的治疗 |
WO2014043208A1 (en) * | 2012-09-11 | 2014-03-20 | Medivation Prostate Therapeutics, Inc. | Formulations of enzalutamide |
WO2015022349A1 (en) * | 2013-08-14 | 2015-02-19 | Ratiopharm Gmbh | Dosage form comprising enzalutamide |
WO2015049650A1 (en) * | 2013-10-01 | 2015-04-09 | Glaxosmithkline Intellectual Property (No.2) Limited | Enzalutamide in combination with afuresertib for the treatment of cancer |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018037310A1 (en) | 2016-08-20 | 2018-03-01 | Ftf Pharma Private Limited | Pharmaceutical composition comprising an androgen receptor inhibitor |
US20190209469A1 (en) * | 2016-08-20 | 2019-07-11 | Ftf Pharma Private Limited | Pharmaceutical composition comprising an androgen receptor inhibitor |
CN109276552A (zh) * | 2017-07-21 | 2019-01-29 | 浙江京新药业股份有限公司 | 一种治疗前列腺癌的抗雄激素类药物软胶囊及其制备方法 |
CN110478347B (zh) * | 2018-05-14 | 2021-07-02 | 海创药业股份有限公司 | 一种hc-1119制剂及其制备方法和用途 |
CN110478347A (zh) * | 2018-05-14 | 2019-11-22 | 成都海创药业有限公司 | 一种hc-1119制剂及其制备方法和用途 |
JP2021523195A (ja) * | 2018-05-14 | 2021-09-02 | ヒノバ ファーマシューティカルズ インコーポレイテッド | Hc−1119製剤及びその製造方法と使用 |
RU2777008C2 (ru) * | 2018-05-14 | 2022-08-02 | Хинова Фармасьютикалс Инк. | Состав hc-1119, способ его получения и применение |
JP7301883B2 (ja) | 2018-05-14 | 2023-07-03 | ヒノバ ファーマシューティカルズ インコーポレイテッド | Hc-1119製剤及びその製造方法と使用 |
CN112336700A (zh) * | 2019-08-08 | 2021-02-09 | 河北菲尼斯生物技术有限公司 | 一种稳定的含丁苯酞药物及其制备方法 |
CN112336700B (zh) * | 2019-08-08 | 2023-12-01 | 河北菲尼斯生物技术有限公司 | 一种稳定的含丁苯酞药物及其制备方法 |
CN113967198A (zh) * | 2020-07-24 | 2022-01-25 | 鲁南制药集团股份有限公司 | 一种甾体cyp17抑制剂胶囊及其制备方法 |
CN114053243A (zh) * | 2020-08-05 | 2022-02-18 | 齐鲁制药有限公司 | 一种恩扎卢胺软胶囊及其制备方法 |
CN112137989A (zh) * | 2020-10-29 | 2020-12-29 | 瑞阳制药股份有限公司 | 恩杂鲁胺软胶囊速释制剂及其制备方法 |
CN112137989B (zh) * | 2020-10-29 | 2024-01-30 | 瑞阳制药股份有限公司 | 恩杂鲁胺软胶囊速释制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104857517B (zh) | 2018-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104857517A (zh) | 一种恩杂鲁胺软胶囊及其制备方法 | |
CN1088362C (zh) | 阿齐霉素的给药方法 | |
NO329912B1 (no) | Sammensetninger omfattende celecoxib | |
AU2011207061B2 (en) | Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof | |
US20240082160A1 (en) | Amlodipine dry suspension and preparation method therefor | |
CN102600132A (zh) | 一种含氨磺必利的口服制剂 | |
CN102670490A (zh) | 一种伊曲康唑口服溶液及其制备方法 | |
CN1709236A (zh) | 一种含有多西他赛的脂肪乳剂及其制备方法 | |
JP7301883B2 (ja) | Hc-1119製剤及びその製造方法と使用 | |
CN109394724B (zh) | 一种丁基苯酞液体硬胶囊制剂及其制备方法 | |
CN104095816B (zh) | 叶黄素酯纳米颗粒及其制备方法 | |
CN109172547A (zh) | 一种宠物用自微乳化口腔速溶膜剂及其制备方法 | |
CN1680390A (zh) | 卤代二氢青蒿素及其制备方法以及用途 | |
CN102579403B (zh) | 盐酸度洛西汀药物组合物 | |
CN106387352A (zh) | 一种含茶多酚的微胶囊动物免疫增强剂及其制备方法 | |
CN115501180A (zh) | 一种甲氨蝶呤脂肪乳注射剂及其制备方法 | |
CN107569473B (zh) | 一种盐酸氨溴索缓释胶囊及其制备方法 | |
CN102552491B (zh) | 玳玳果总黄酮自微乳化微丸及其制备方法 | |
CN111569045A (zh) | 一种氟苯尼考可溶性粉粉剂药物 | |
CN114533700B (zh) | 一种萘普生口服制剂及其制备方法 | |
CN100375612C (zh) | 珍菊降压滴丸及其制备方法 | |
CN100336505C (zh) | 一种黄豆苷元软胶囊及其制备方法 | |
CN112137989B (zh) | 恩杂鲁胺软胶囊速释制剂及其制备方法 | |
RU2777008C2 (ru) | Состав hc-1119, способ его получения и применение | |
CN102370629A (zh) | 恩替卡韦液体胶囊及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 210009, A15 building, 5 new model road, Jiangsu, Nanjing Applicant after: Nanjing Haina pharmaceutical Polytron Technologies Inc Address before: 210009, A15 building, 5 new model road, Jiangsu, Nanjing Applicant before: Nanjing Healthnice Medical Technology Co., Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180420 Address after: 210009, A15 building, 5 new model road, Jiangsu, Nanjing Co-patentee after: Nanjing Haina Pharmaceutical Co., Ltd. Patentee after: Nanjing Haina pharmaceutical Polytron Technologies Inc Address before: 210009, A15 building, 5 new model road, Jiangsu, Nanjing Patentee before: Nanjing Haina pharmaceutical Polytron Technologies Inc |
|
TR01 | Transfer of patent right |